In a phase @ efficacy trial of a tetravalent dengue vaccine in five Latin American countries where dengue is endemic , we randomly assigned healthy children between the ages of @ and @ years in a @:@ ratio to receive three injections of recombinant , live , attenuated , tetravalent dengue vaccine ( CYD-TDV ) or placebo at months @ , @ , and @ under blinded conditions .